Effect of bariatric surgery on systemic and adipose tissue inflammation

Surgical Endoscopy

Volumn 30, Issue 8, 2016, Pages 3499-3504

  Sams, Valerie G ^a,c   Blackledge, Camille ^a   Wijayatunga, Nadeeja ^b   Barlow, Patrick ^a   Mancini, Matthew ^a   Mancini, Gregory ^a   Moustaid Moussa, Naima ^a,b  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

Adipokines; Bariatric surgery; Insulin resistance

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC BANDING; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; LAPAROSCOPIC ROUX EN Y GASTRIC BYPASS; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH BYPASS; SUBCUTANEOUS FAT; SUBCUTANEOUS FAT DISORDER; TISSUE LEVEL; BLOOD; GASTRIC BYPASS SURGERY; GASTROPLASTY; LAPAROSCOPY; METABOLISM;

ADIPONECTIN; ADULT; BIOMARKERS; CHEMOKINE CCL2; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945549079     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-015-4638-3     Document Type: Article

References (25)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM (2013) Prevalence of obesity among adults: United States, 2011–2012. NCHS Data Brief 131:1–8
2. Poirier P, Cornier M-A, Mazzone T et al (2011) Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation 123(15):1683–1701
3. Flegal KM, Kit BK, Orpana H, Graubard BI (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309(1):71–82
4. Colquitt JL, Pickett K, Loveman E, Frampton G (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev 8:CD003641
5. Knop FK, Taylor R (2013) Mechanism of metabolic advantages after bariatric surgery: it’s all gastrointestinal factors versus it’s all food restriction. Diabetes Care 36(Supplement 2):S287–S291
6. Feng B, Zhang T, Xu H (2013) Human adipose dynamics and metabolic health. Ann N Y Acad Sci 1281(1):160–177
7. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11(2):85–97
8. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB (2006) Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2:264–280
9. Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K (2003) Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88(4):1594–1602
10. Kwon H, Pessin JE (2013) Adipokines mediate inflammation and insulin resistance. Front Endocrinol 4:71
11. Mun EC, Blackburn GL, Matthews JB (2001) Current status of medical and surgical therapy for obesity. Gastroenterology 120:669–681
12. Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693
13. Buchwold H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737
14. Shah M, Simha V, Garg A (2006) Long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 91(11):4223–4231
15. Thaler JP, Cummings DE (2009) Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150(6):2518–2525
16. Andreelli F, Amouyal C, Magnan C, Mithieux G (2009) What can batriatric surgery teach us about the pathophysiology of type 2 diabetes? Diabetes Metab 35(6pt2):499–507
17. Kalupahana NS, Voy BH, Fletcher S et al (2009) Mechanisms linking overproduction of angiotensinogen by adipose tissue to inflammation, glucose intolerance and insulin resistance. Obesity 17(suppl2):S58
18. Kanda H, Tateya S, Tamori Y et al (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis on obesity. J Clin Investig 116:1494–1505
19. Sato C, Shikata K, Hirota D et al (2011) P-selectin glycoprotein ligand-1 deficiency is protective against obesity-related insulin resistance. Diabetes 60:189–199
20. Weisberg SP, Hunter D, Huber R et al (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Investig 116:115–124
21. Hotamisligil GS, Shargil NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
22. Luo N, Liu J, Chung BH et al (2010) Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes 59:791–799
23. Rubino F, Schauer PR, Lee KM, Cummings DE (2010) Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 61:393–411
24. Pournaras DJ, Aasheim ET, Bueter M et al (2012) Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss. Surg Obes Relat Dis 8(4):371–374
25. Miller GD, Nicklas BJ, Fernandez A (2011) Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis 7(5):618–624